The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

This article previews some formulation topics discussed in the Pharma Fundamentals series, which aims to enhance learning for professionals in pharmaceutical drug development and manufacturing. It is ...

Sun Pharmaceutical Industries clocked a net profit of ₹3,118 crore, for the second quarter ended September 30, up 2.6 per ...

To mitigate these challenges, it is critical to identify and implement an appropriate enabling formulation strategy early in the development process. Doing so can de-risk your program and reduce costs ...

Ankleshwar, India – July 22, 2024 – RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...

Nigel Langley of gChem stresses excipient innovation, safer solvents, and supply chain resilience for pharma’s future in part ...

Aurobindo Pharma Ltd (BOM:524804) reports robust revenue growth and operational efficiency, with significant contributions from European markets and strategic advancements in its biosimilar pipeline.

Aurobindo Pharma reported September quarter consolidated net profit rose nearly 4% to ₹848 crore compared with ₹817 crore a ...

Sun Pharmaceutical Industries has reported 2.6% rise in consolidated net profit to Rs 3,118 crore on a 8.6% increase in revenue to Rs 14,405.2 crore in Q2 FY26 as compared with Q2 FY25.